MedPath

COVID-19 and Social Isolation and Loneliness Trial

Not Applicable
Conditions
Loneliness
Geriatric
Social Isolation
Interventions
Other: HOW R U? Intervention
Registration Number
NCT05228782
Lead Sponsor
Mount Sinai Hospital, Canada
Brief Summary

Social isolation and loneliness worsen older peoples' quality of life, risk of dementia, and contributes to 45,000 deaths/year in Canada - as much as smoking. Isolated people use the health care system more often, but have worse outcomes. Effective, inexpensive interventions exist but unfortunately they have not been implemented in Canada.

We partnered with the Australian developer of HOW R U?, an effective and feasible intervention that uses specially trained, older, hospital volunteers to provide peer support to combat isolation and loneliness in isolated older peers.

Little is known about older people's preferences for virtual care (telephone vs. video) nor their relative effectiveness. Thus we will compare two ways of delivering HOW R U: telephone support and a tested, secure user-friendly video conferencing app, aTouch Away® to a common control arm.

We also partnered with Emergency Medicine, Family Medicine, Geriatrics and Psychiatry to identify people who will benefit from peer support; and with Volunteer Services to recruit volunteers.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
141
Inclusion Criteria
  • Any community-dwelling person 70 years of age and older receiving care from the ED, Family Medicine, or Geriatric clinics at our two participating sites (MSH and NYGH) will be eligible.
Exclusion Criteria
  • age less than 70 years; communication problems (critically ill, unconscious, language barrier, speech impairment or otherwise unable to provide consent), or admission to a hospital for > 72 hours. Patients with severe cognitive impairment or those living in nursing homes who are dependent on others for their activity of daily living will be excluded. To target the intervention for older people with loneliness a baseline de Jonge loneliness scores of 2.0 will be required for participation in the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HOW RU Intervention delivered by video-callHOW R U? InterventionGroup Video will receive the HOW RU? intervention delivered over video-call using the aTouch Away platform.
HOW RU Intervention delivered by telephoneHOW R U? InterventionGroup Phone will receive the HOW RU? intervention over the telephone.
Primary Outcome Measures
NameTimeMethod
Change in De Jong Gierveld Loneliness Scale at BaselineThis scale will be collected at baseline and at 12 weeks.

We will use the 6-item De Jong Gierveld loneliness scale as our primary outcome measure.The minimum value is 0 and the maximum value is 6.

Secondary Outcome Measures
NameTimeMethod
Change in Social NetworkBaseline and at 12 weeks

Lubben's Social Network Scale

Change in MoodBaseline and at 12 weeks

Geriatric Depression Scale

Change in Quality of lifeBaseline and at 12 weeks

EQ-5D-5L survey

all-cause mortalityFollow-up phone call at 12 weeks

Trial Locations

Locations (1)

Mount Sinai Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath